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distinct contributions from unfolded
protein response components
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Abstract
Background: Cell death triggered by unmitigated endoplasmic reticulum (ER) stress plays an important role in
physiology and disease, but the death-inducing signaling mechanisms are incompletely understood. To gain more
insight into these mechanisms, the ER stressor thapsigargin (Tg) is an instrumental experimental tool. Additionally,
Tg forms the basis for analog prodrugs designed for cell killing in targeted cancer therapy. Tg induces apoptosis via
the unfolded protein response (UPR), but how apoptosis is initiated, and how individual effects of the various UPR
components are integrated, is unclear. Furthermore, the role of autophagy and autophagy-related (ATG) proteins
remains elusive.
Methods: To systematically address these key questions, we analyzed the effects of Tg and therapeutically relevant
Tg analogs in two human cancer cell lines of different origin (LNCaP prostate- and HCT116 colon cancer cells),
using RNAi and inhibitory drugs to target death receptors, UPR components and ATG proteins, in combination with
measurements of cell death by fluorescence imaging and propidium iodide staining, as well as real-time RT-PCR
and western blotting to monitor caspase activity, expression of ATG proteins, UPR components, and downstream
ER stress signaling.
Results: In both cell lines, Tg-induced cell death depended on death receptor 5 and caspase-8. Optimal cytotoxicity
involved a non-autophagic function of MAP1LC3B upstream of procaspase-8 cleavage. PERK, ATF4 and CHOP were
required for Tg-induced cell death, but surprisingly acted in parallel rather than as a linear pathway; ATF4 and
CHOP were independently required for Tg-mediated upregulation of death receptor 5 and MAP1LC3B proteins,
whereas PERK acted via other pathways. Interestingly, IRE1 contributed to Tg-induced cell death in a cell type-
specific manner. This was linked to an XBP1-dependent activation of c-Jun N-terminal kinase, which was pro-
apoptotic in LNCaP but not HCT116 cells. Molecular requirements for cell death induction by therapy-relevant Tg
analogs were identical to those observed with Tg.
Conclusions: Together, our results provide a new, integrated understanding of UPR signaling mechanisms and
downstream mediators that induce cell death upon Tg-triggered, unmitigated ER stress.
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Background
Insufficient capacity of the endoplasmic reticulum (ER)
to fold newly synthesized proteins leads to accumulation
of unfolded proteins in the ER; a situation referred to as
“ER stress”. In response to ER stress, the cell initiates the
“unfolded protein response” (UPR), which by different
means aims to restore the balance between ER folding
capacity and unfolded protein load. If the cell fails to re-
store this balance, the resulting chronic ER stress and
persistent UPR signaling leads to cell death [1]. Cell
death induced by unresolved ER stress is implicated in a
growing list of pathophysiological conditions, including
neurological and cardiovascular diseases, ophthalmology
disorders, viral infections, and diabetes [2–4]. In many
of these cases, the pathophysiology is linked to decreased
levels of ER Ca2+ [3], which leads to ER stress and UPR
due to the dependency of the ER protein folding ma-
chinery on ER lumenal Ca2+ [5, 6]. If we can understand
the molecular mechanisms that initiate cell death under
such conditions, it can lay the ground for the develop-
ment of novel treatment modalities for various diseases.
Experimentally, ER Ca2+ depletion and a resulting
UPR can be achieved by use of the specific sarco/endo-
plasmic reticulum Ca2+-ATPase (SERCA) inhibitor thap-
sigargin (Tg; for chemical structure see Additional file 1:
Figure S1A) - a classical tool to study ER stress and UPR
biology. Tg produces sustained and unmitigated ER
stress in mammalian cells, leading to UPR-induced
apoptosis [7–13]. Besides its use as an experimental tool,
Tg is the mother compound of prodrugs designed for
use in targeted cancer therapy [14–16]. In the current
study, we set out to explore the signaling mechanisms of
cell death induction by Tg and Tg analogs derived from
Tg prodrugs (Additional file 1: Figure S1A) in two differ-
ent cancer cell lines (LNCaP and HCT116), with the
overarching aims to: (i) enhance our understanding of
ER stress-induced signaling to cell death with a particu-
lar relevance to diseases associated with UPR-induced
apoptosis and decreased levels of ER Ca2+, and (ii) better
understand the mechanisms of action of therapeutically
relevant Tg analogs. We focused in particular on defin-
ing upstream cell death-initiating events and how the
various components of the UPR integrate on them – an
important area of investigation wherein, as described
below, many key questions are unresolved.
Multiple studies indicate that unmitigated ER stress initi-
ates cell death via the extrinsic pathway. Tg and other ER
stressors frequently upregulate the mRNA and protein
levels of death receptor 5 (DR5; TRAIL-R2) [9, 13, 17–22]
and initiate DR5- [9, 13, 18–21] and caspase-8- [9, 18, 21–
25] dependent cell death in various cell types. However,
death receptors other than DR5 have also been implicated
in ER stress-induced apoptosis, including death receptor 1
(DR1; TNFR1) [26], death receptor 2 (DR2; Fas) [27], and
death receptor 4 (DR4; TRAIL-R1) [19, 20]. The relative
importance of the various death receptors in ER stress-
induced cell death is unknown, since, to the best of our
knowledge, no single study has directly compared their in-
volvements. In the current study, we found Tg-induced up-
regulation of DR5 to be strongly required for activation of
caspase-8 and cell death in both LNCaP and HCT116 cells,
while other death receptors played a minor or no role.
Autophagy and autophagy-related (ATG) proteins are
frequently implicated in cell death regulation [28], but
their role in ER stress-induced cell death is unclear. ER
stress potently upregulates the expression of microtubule-
associated proteins 1A/1B light chain 3B (LC3B), as well
as other ATGs [29–33]. This correlates with enhanced au-
tophagic flux in cells treated with the ER stressor tunica-
mycin (Tm) [30], whereas Tg blocks general autophagy
due to ER Ca2+ depletion [11, 33]. Variable and inconsist-
ent results have been reported with respect to the effect of
genetic depletion of key ATGs (Beclin1 or ATG5) on Tg-
and Tm-induced cell death [25, 34–37]. Thus, additional
research is needed to define the role of autophagy and
ATGs in ER stress-induced cell death. In both LNCaP and
HCT116 cells, we found LC3B, but not other central
ATGs (ATG5, FIP200, GABARAPs), to be required for
optimal Tg-induced cell death. Moreover, LC3B acted up-
stream of caspase-8 activation.
Having defined ER stress-induced DR5 and LC3B upregu-
lation as important cell death-initiating signaling events, we
aimed to delineate the individual contributions from the dif-
ferent UPR components to DR5 and LC3B expression, as
well as to caspase activation and cell death. The UPR is clas-
sically divided into the PERK, IRE1, and ATF6 arms [1, 38].
Upon accumulation of unfolded proteins in the ER, the
protein kinase PERK is activated via dimerization and trans-
autophosphorylation. Active PERK subsequently phosphory-
lates downstream targets, including eukaryotic initiation
factor 2α. The latter event leads to a transient block in gen-
eral protein synthesis, while favoring translation of selected
transcripts, including ATF4. ATF4 is a transcription factor
that controls the expression of numerous genes, including
the transcription factor CHOP. Upon ER stress, IRE1 dimer-
izes/oligomerizes, trans-autophosphorylates, and acquires
RNase activity. The latter results in alternative splicing of
XBP1, producing the transcription factor XBP1s. Add-
itionally, the IRE1 RNase activity triggers the cleavage and
degradation of a broad range of transcripts via a mechan-
ism termed regulated IRE1-dependent decay (RIDD). IRE1
can also interact with TRAF2 and ASK1, leading to activa-
tion of c-Jun N-terminal kinase (JNK) [39, 40]. Finally,
upon ER stress, ATF6 translocates to the Golgi apparatus,
where proteolytic cleavage releases the ATF6 transcription
factor fragment.
CHOP has been demonstrated to play an important role
in ER stress-induced DR5 upregulation and cell death [9,
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13, 18], but the precise roles of PERK and ATF4 are yet to
be experimentally determined. It is important to point out
that, even though often assumed, the PERK-ATF4-CHOP
axis is not necessarily a strictly linear pathway. In fact,
under some circumstances, ER stress-induced elevation of
ATF4 protein levels can occur independently of PERK [30]
and ER stress-mediated induction of CHOP can occur in-
dependently of ATF4 [41]. Moreover, PERK can exert cel-
lular effects via other mechanisms than through ATF4 [30,
38, 41–44], and ATF4 has many target genes other than
CHOP [41, 45]. Consequently, careful experimental study is
required to determine the individual roles of PERK, ATF4,
and CHOP in ER stress-induced regulation of cell death
and DR5 expression. The same applies to the regulation of
LC3B expression, where separate studies have implicated
various components of the PERK branch [30, 32, 36, 46],
but where the delineation of the individual roles played by
PERK, ATF4 and CHOP is incomplete.
The role of IRE1 in ER stress-induced cell death is com-
plex and yet to be fully understood. A pro-survival function
of IRE1-XBP1 signaling has been suggested, since forced
enhancement of IRE1-mediated XBP1 splicing can protect
cells from ER stress-induced apoptosis [47]. Moreover,
XBP1 depletion can sensitize cells that are exposed to low-
level cytotoxic ER stress [48]. However, the precise role
played by the endogenously activated IRE1-XBP1 pathway
during unopposed, cytotoxic ER stress is yet to be defined.
Several studies indicate that IRE1 contributes to ER stress-
induced cell death via its RIDD activity [49–51]. However,
another study proposed that specific IRE1 RIDD activity to-
wards DR5 mRNA opposes ER stress-induced cell death
[9]. Finally, a number of studies suggest that IRE1 can con-
tribute to ER stress-induced cell death via activation of JNK
[39, 52–54]. Contrasting results have been reported with re-
gard to the overall, net effect of IRE1 on ER stress-induced
cell death [9, 18, 49], and opposing results obtained with
the same ER stressor (Tg) in different cell lines [9, 18, 49]
suggest a cell type-dependent role of IRE1. However, mo-
lecular explanations for such cell type-specific differences
are lacking. The role of ATF6 in ER stress-induced cell
death has been much less studied than the two other UPR
branches. However, a pro-survival role for ATF6 has been
observed in response to chronic, mild ER stress [55], and
knockdown of ATF6 was reported to sensitize melanoma
cells to apoptosis induction by Tm or Tg [56]. Apart from
the influence of IRE1 on DR5 described above [9], the roles
of IRE1, XBP1, and ATF6 in regulating DR5 and LC3B ex-
pression during death-inducing ER stress stimuli have not
been examined previously.
In this study, we undertook a systematic RNAi-based
approach to delineate the roles of the UPR components
in Tg-induced regulation of DR5 and LC3B expression,
and cell death. We found ATF4 and CHOP to be indi-
vidually required for the upregulation of both DR5 and
LC3B, as well as for cell death, whereas PERK was re-
quired for cell death but not for upregulation of DR5
and LC3B protein. ATF6 knockdown neither reduced
cell death nor DR5 or LC3B expression. IRE1 and XBP1
were partially required for Tg-induced cell death in
LNCaP but not HCT116 cells, and partially required for
upregulation of DR5, but not LC3B. Notably, we found
that IRE1 activated JNK in an XBP1-dependent manner,
and JNK was required for Tg-induced cell death in
LNCaP cells, without affecting DR5 or LC3B expression.
The inability of IRE1-XBP1 to influence Tg-induced cell
death in HCT116 cells was associated with Tg-induced
cell death being independent of JNK in this cell line.
Lastly, we examined the mechanisms of cell death induc-
tion by active components of therapeutically relevant Tg
prodrugs. Inactive, cell impermeable Tg prodrugs contain a
12-aminododecanoyl linker with specific peptide sequences
that are cleaved by tumor-produced proteolytic enzymes,
thereby generating active, cell permeable Tg analogs only in
the vicinity of the tumor [14–16]. Tg prodrugs have shown
impressive tumor-eradicating effects in preclinical animal
models [14, 15, 57, 58]. Moreover, one prodrug has reached
the stage of clinical phase II trials, where it recently was
demonstrated to promote prolonged disease stabilization in
patients with advanced hepatocellular carcinoma [59].
Prodrug-derived Tg analogs induce apoptotic cell death
correlated with sustained UPR induction in cancer cells
[10], but other than that little is known about how the ef-
fects of the Tg analogs compare to those of Tg. Strikingly,
our focussed RNAi-based screening approach revealed vir-
tually identical molecular requirements for cell death in-
duced by therapeutically relevant Tg analogs as those we
had identified for Tg, in both LNCaP and HCT116 cells.
Materials and methods
Chemicals
Thapsigargin (Tg) was purchased from Sigma (T9033).
The Tg analogs 8-O-debutanoyl-8-O-N-L-Leucinoyl-12-
aminododecanoylthapsigargin (Leu-8ADT) and 8-O-
debutanoyl-8-O-N-L-β-aspartoyl-12-aminododeca-
noylthapsigargin (βAsp-8ADT) were synthesized as pre-
viously described [60]. The PERK inhibitor GSK2606414
[61] was a kind gift from Dr. Jeffrey M. Axten (GlaxoS-
mithKline). The JNK inhibitor JNK-IN-8 was from
Sigma (SML1246). The chemical structures of Tg, Leu-
8ADT, βAsp-8ADT, GSK2606414, and JNK-IN-8 are
depicted in Additional file 1: Figure S1.
Cell culture and siRNA transfections
LNCaP prostate cancer cells (ATCC, CRL-1740) and
HCT116 colorectal carcinoma cells (ATCC, CCL-247)
were cultured in RPMI 1640 (Thermo Fisher Scientific,
21875091) or DMEM/F12 (Thermo Fischer Scientific,
11320074) medium, respectively, containing 10% FBS
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(Sigma, F7524 batch BCBT0730) at 37 °C in a humidified
incubator containing 5% CO2. RNAi -mediated knock-
down was performed by reverse transfection, using RNAi-
Max (Invitrogen 13778) and 5 nM siRNA, according to
the manufacturer's protocol. The following Silencer Select
siRNAs (Ambion) were used: siCtrl (non-targeting nega-
tive Control, 4390843), siATF4–1 (s1704), siATF4–2
(s1702), siATF6–1 (s223544), siATF6-2 (s223545), siCas-
pase8–1 (s2425), siCaspase8–2 (s2427), siCHOP-1
(s3996), siCHOP-2 (s3997), siDR4 (s16764), siDR5–1
(s225037), siDR5–2 (s16756), siFADD (s228426), siFas
(s223933), siGABARAP (s22361), siGABARAPL1
(s24332), siGABARAPL2 (s22385), siFIP200 (s18995),
siIRE1–1 (s200432), siIRE1–2 (s200430), siLC3B-1
(s37748), siLC3B-2 (s224886), siPERK-1 (s18101), siPERK-
2 (s18103), siTRADD (s16607), siXBP1–1 (s14913),
siXBP1–2 (s14914), and the following ON-TARGET plus
siRNAs from Darmacon: siCtrl (non-targeting negative
Control, D-001810-01–20) and siATG5 (J-004374-07).
Cell death measurements
Cell death was assessed by live-cell fluorescence imaging
of propidium iodide-stained cells as previously described
[10, 62]. Briefly, cells were seeded in triplicates in 96-well
plates and grown to ~ 60–80% confluency. Treatments
were added along with 2.5 μg/ml (final concentration) pro-
pidium iodide to stain for dead cells, and the IncuCyte
ZOOM imaging system (Essen Bioscience) was used for
live-cell phase-contrast and fluorescence imaging, acquir-
ing 3 images from each well every 3 h. The integrated soft-
ware was used to calculate ratios of red fluorescence- to
total cell confluency, as previously described [10, 62]. The
data was normalized to the average ratio from each ex-
periment. Relative cell death compared to Tg-treated con-
trol cells was quantified at 48 h (LNCaP) or 39 h
(HCT116). These time points represent the boundary be-
tween the linear and asymptotic regions in the typical sig-
moid curves that are obtained upon plotting cell death
versus time in Tg-treated cells [10, 62], and when more
than 50% of the cells were dead in the Tg-treated siCtrl-
transfected condition [10, 62] (and data not shown).
Immunoblotting
Cells were harvested after 30 h of treatment with Tg, unless
otherwise stated. Preparation of whole-cell lysates, SDS-
PAGE, and immunoblot analysis were performed as de-
scribed previously [33]. The following antibodies were used:
alpha-tubulin (Abcam, ab7291), ATG5 (Cell Signaling Tech-
nology 2630), ATF4 (Cell Signaling Technology 11815),
Bip/Grp78 (Cell Signaling Technology 3177), Caspase-3
(8G10) (Cell Signaling Technology 9665), Caspase-8 (1C12)
(Cell Signaling Technology 9746), CHOP (Cell Signaling
Technology 2895), Cleaved PARP (Asp214) (D64E10) (Cell
Signaling Technology 5625), DR5 (Cell Signaling
Technology 8074), FADD (G-4) (Santa Cruz sc-271748),
FIP200 (Proteintech 17250–1-AP, GABARAP (Proteintech
PM037), GABARAPL1 (Abcam ab86497), GABARAPL2
(Proteintech PM038), p-JNK (Cell Signaling Technology
9251), JNK (Cell Signaling Technology 9252), LC3B (Cell
Signaling Technology 2775), PERK (Cell Signaling Technol-
ogy 5683), XBP1s (BioLegend 647502).
Real-time RT-PCR
Total RNA was isolated from cell pellets using the Relia-
Prep RNA Miniprep Systems (Promega) according to
manufacturer's instructions. Reverse transcription was
performed using SuperScript VILO Master Mix (Applied
Biosystems 11,755,250) and subsequently mRNA levels
were determined by real-time PCR using TaqMan gene
expression assays (Appl. Biosys. 11755250) with TaqMan
fast advanced PCR master mix (Appl. Biosys. 4444558).
PCR amplification was done in triplicate measurements
per sample with the ABI 7900HT FAST sequence detec-
tion system (Appl. Biosys.). The cycling conditions were
50 °C for 2 min, 95 °C for 10 min, 40 cycles at 95 °C for
15 s and 60 °C for 1 min. Relative mRNA levels were
normalization to the geometric mean CT value of
GAPDH and TBP, and thereafter calculated by the com-
parative CT method compared to the DMSO treated
control cells (set as 1). The following TaqMan
probes (Appl. Biosys.) were used: ATF4 Hs00909569_g1,
ATF6 Hs0023586_m1, DDIT3 (CHOP) Hs00358796_g1,
EIF2AK3 (PERK) Hs00984003_m1, ERN1 (IRE1)
Hs00176385_m1, FAS Hs00236330_m1, GAPDH
Hs99999905_m1, MAP1LC3B Hs00797944_s1, TBP
Hs99999910_m1, TNFRSF10A (DR4) Hs00269492_m1,
TNFRSF10B (DR5) Hs00366278_m1, TRADD
Hs00601065_g1, XBP1 Hs02856596_m1, XBP1s
Hs0329085_g1.
Statistics and calculation of RNAi-mediated effects on cell
death and protein expression
Data are reported as mean of at least 3 independent exper-
iments with SEM as error bars, unless otherwise indicated.
To determine significance levels, repeated measures one-
way analysis of variance (ANOVA) with Dunnett’s mul-
tiple comparison test was performed using GraphPad
Prism 8. Significance was assumed if P < 0.05. The effect
of a specific siRNA, here denoted as “siX”, on Tg-induced
cell death or upregulation of protein expression, as com-
pared to the basal levels observed in the siCtrl+DMSO
condition, was calculated as follows: The difference be-
tween the average values obtained in the siCtrl+Tg condi-
tion versus the siX+Tg condition was divided by the
difference between the average values obtained in the
siCtrl+Tg condition versus the siCtrl+DMSO condition,
and next multiplied by 100 to present the percentage
effect.
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Results
DR5 and caspase-8 are main initiators of Tg-induced cell
death in LNCaP and HCT116 cells
ER stress-induced apoptosis has been linked to increased ex-
pression of DR5 and activation of caspase-8 in multiple cell
types and conditions [9, 13, 17–24], but may also involve
DR1 (TNFR1) [26], DR2 (Fas) [27], and DR4 (TRAIL-R1)
[19, 20]. To our knowledge, no single study has so far per-
formed a side-by-side comparison of the relative roles
played by the various death receptors in ER stress-induced
cytotoxicity. To elucidate the putative involvement of differ-
ent death receptors in Tg-induced cell death in LNCaP and
HCT116 cells, we knocked down DR4, DR5 or Fas, or the
adaptor proteins FADD and TRADD, which are crucial for
cell death induction by death receptors 2, 4, and 5 (FADD)
or death receptors 1, 3, and 6 (TRADD), and assessed the
effects on Tg-induced cell death. DR5 silencing strongly re-
duced Tg-induced cell death in both cell lines (Fig. 1a; Add-
itional file 1: Figure S2A), and potently diminished Tg-
mediated cleavage of caspase-3 and the caspase-3/7-sub-
strate PARP in both lines (Fig. 1b-d; Additional file 1: Figure
S2B, S2D, S2E). Moreover, DR5 depletion virtually abolished
Tg-induced caspase-8 cleavage in HCT116 cells (Additional
file 1: Figure S2B, S2C). Of note, we could not determine
caspase-8 cleavage in LNCaP cells because of too faint
bands in the immunoblots (Fig. 1b), in spite of testing a
number of different anti-caspase-8 antibodies (not shown).
Tg enhanced DR5 protein levels by approximately 3-fold
and 9-fold in LNCaP and HCT116 cells, respectively (Add-
itional file 1: Figure S3).
Knockdown of caspase-8 virtually completely blocked
Tg-induced cell death as well as caspase-3- and PARP
cleavage in both cell lines (Fig. 1; Additional file 1: Fig-
ure S2). In contrast, silencing of DR4 or TRADD (see
Additional file 1: Figure S4 for knockdown efficiencies)
failed to reduce Tg-induced cell death and caspase acti-
vation (Fig. 1; Additional file 1: Figure S2). Rather, there
was a tendency of a slight increase in Tg-induced cell
death and caspase activation in TRADD-silenced LNCaP
and HCT116 cells, as well as in DR4-silenced HCT116
cells. These effects did not correlate with any change in
DR5 protein expression upon DR4 or TRADD knock-
down (Additional file 1: Figure S3). Interestingly, Tg
produced a 4- and 2-fold increase in TRADD mRNA
levels in LNCaP and HCT116 cells, respectively, and a
2-fold increase in DR4 mRNA levels in HCT116 cells
(Additional file 1: Figure S4, B-D), indicating that Tg
may limit its own cytotoxicity via these upregulations.
Fig. 1 Tg-induced cell death depends on DR5 and caspase-8, and partially requires FADD and Fas, but not DR4 or TRADD in LNCaP cells. a
LNCaP cells were transfected for 2 d with the indicated siRNAs (siCtrl = non-targeting control siRNA, siCasp8 = siCaspase-8). Subsequently, cells
were treated with 100 nM Thapsigargin (Tg) or 0.01% DMSO vehicle control (“DMSO”, also transfected with siCtrl) in the additional presence of
2.5 μg/ml propidium iodide to stain dead cells. Cell death was monitored and quantified with the IncuCyte ZOOM as described in Materials and
Methods, and displayed as relative values normalized to those obtained in the siCtrl+Tg condition after 48 h of treatment (mean value set to 1). b
LNCaP cells were transfected and treated as in (a). After 30 h of treatment with Tg or DMSO (also transfected with siCtrl), whole cell lysates were
prepared and subjected to western blotting with the indicated antibodies; p55/53 Casp8 = procaspase-8, Casp3 = caspase-3 (only cleaved
caspase-3 bands are shown), cl-PARP = cleaved PARP. The positions of molecular weight markers are indicated to the left, and nonspecific bands
marked with an asterisk. One representative blot out of 4 independent experiments. c and d Quantifications of the protein levels of cleaved
Caspase-3 (c) and cleaved PARP (d), normalized to the tubulin loading control and then to the Tg + siCtrl condition (mean value set to 1). For (a,
c, and d): Mean ± SEM from 4 independent experiments. Dots represent individual values, with a separate color for each experiment. *P < 0.05,
**P < 0.01, ***P < 0.001, ns; not significant, One-way ANOVA compared to the Tg + siCtrl condition
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Combined knockdown of DR4 and DR5 did not further
reduce Tg-induced cell death or caspase activation com-
pared to that obtained upon knockdown of DR5 alone
(Fig. 1; Additional file 1: Figure S2). Thus, DR4 was nei-
ther required for Tg-induced cell death nor could com-
pensate for the lack of DR5 with regard to Tg-induced
cell death, in any of the cell lines.
Tg and other ER stressors have been reported to induce
cell death via an intracellular, ligand-independent DR5-
nucleated DISC [9, 18]. In agreement, TRAIL-targeted
RNAi did not affect Tg-induced cell death (Additional file
1: Figure S5). Although a Tg-induced DR5-nucleated
DISC containing FADD and caspase-8 has been demon-
strated [9], a specific requirement for FADD in Tg-
induced cell death has not been previously examined. In
LNCaP cells, FADD silencing efficiently reversed Tg-
induced caspase-3 cleavage (Fig. 1b and c), but could only
partially reduce Tg-induced cell death and PARP cleavage
(Fig. 1a and d). Knockdown of FADD with a second
FADD-targeting siRNA likewise only partially reversed
Tg-induced cell death (data not shown). In HCT116 cells,
FADD knockdown did not significantly alter Tg-induced
cell death nor Tg-induced cleavage of caspase-8, caspase-3
or PARP, although there were tendencies of a reduction in
Tg-induced caspase-3- and PARP cleavage (Additional file
1: Figure S2). This indicates that proteins other than
FADD may contribute to Tg-induced DR5-mediated
caspase-8 activation and cell death. Combined knockdown
of FADD and TRADD did not reduce Tg-induced cell
death or caspase activation compared to that observed
upon knockdown of FADD alone (Fig. 1; Additional file 1:
Figure S2). Thus, TRADD could not compensate for the
lack of FADD. Interestingly, Tg-induced cell death was
slightly reduced upon knockdown of Fas in LNCaP cells
(Fig. 1a), accompanied by a tendency of a reduction in Tg-
induced PARP cleavage (Fig. 1b and d). This effect was
not caused by any change in DR5 protein expression upon
Fas knockdown (Additional file 1: Figure S3A). The partial
requirement for Fas was not observed in HCT116 cells.
On the contrary, Fas knockdown slightly increased Tg-
induced cell death and PARP cleavage in HCT116 cells
(Additional file 1: Figure S2A, S2B, S2E).
In conclusion, our results demonstrate that DR5 and
caspase-8 are the main initiators of Tg-induced cell death in
both LNCaP and HCT116 cells. Consolidating this conclu-
sion, we confirmed the potent ability of DR5 and caspase-8
silencing to abrogate Tg-induced cell death and caspase ac-
tivation in both cell lines also with a second set of DR5- and
caspase-8-targeting siRNAs (Additional file 1: Figure S6).
A non-autophagic function of LC3B is partially required
for Tg-induced cell death in LNCaP and HCT116 cells
The UPR can upregulate the expression of LC3B and
other ATGs [29–33], and activate autophagy in LNCaP
and other human cell lines [30]. However, due to very
efficient ER Ca2+ depletion, Tg potently blocks func-
tional autophagy and LC3 flux at a stage prior to phago-
phore closure, potentially resulting in accumulation of
LC3-positive, unclosed autophagosomal membranes
[11, 33]. Autophagosomal membranes can act as signal-
ing platforms for oligomerization and activation of
caspase-8 in response to treatment with proteasome- or
sphingosine kinase inhibitors [63–65]. We therefore hy-
pothesized that Tg-mediated accumulation of LC3-
positive autophagosomal membranes may facilitate
caspase-8 activation and cell death also in response to
Tg-induced ER stress. In line with this hypothesis,
knockdown of LC3B led to a ~ 40% reduction of Tg-
induced cell death and a ~ 30% reduction of Tg-induced
PARP cleavage in LNCaP cells (Fig. 2a-c). Moreover, in
HCT116 cells, LC3B silencing led to ~ 30% reduction of
Tg-induced cell death, a ~ 30% reduction of Tg-induced
procaspase-8 cleavage, and a tendency of a comparable
reduction in PARP cleavage (Fig. 2d-f). Similar results
were obtained with a second LC3B-targeting siRNA,
again with the reduction in Tg-induced cell death being
most pronounced in LNCaP cells (Additional file 2: Fig-
ure S7A, S7B). Tg strongly increased LC3B protein
levels in both LNCaP and HCT116 cells, and LC3B pro-
tein expression was efficiently reduced upon LC3B
RNAi (Fig. 2b and e; Additional file 2: Figure S7C, S7D).
Combined silencing of LC3A and LC3B did not produce
any further reduction in Tg-induced cell death com-
pared to that observed upon silencing of LC3B alone
(data not shown). Hepatitis B virus-induced autophagy
can trigger LC3B-dependent degradation of DR5 [66].
However, and in accordance with Tg blocking func-
tional autophagy [33], knockdown of LC3B did not re-
sult in higher DR5 protein levels in Tg-treated cells
(Additional file 2: Figure S7, C-F). To test if the require-
ment for LC3B in Tg-induced cell death reflected a re-
quirement for autophagosomal membranes, we knocked
down the ATG genes ATG5 and FIP200, which are cru-
cial for phagophore maturation and recruitment of LC3
to the phagophore [67–69], or all three members of the
GABARAP family, which are required for autophago-
some formation [70]. Evidently, silencing of ATG5,
FIP200, or the GABARAP family members did not re-
duce Tg-induced cell death in LNCaP or HCT116 cells
(Additional file 2: Figure S8A, S8D), in spite of very effi-
cient knockdown (Additional file 2: Figure S8B, S8E).
Furthermore, depletion of ATG5, FIP200, or all three
GABARAP family members did not result in higher
DR5 protein levels in Tg-treated cells (Additional file 2:
Figure S8C, S8F), demonstrating - again in accordance
with Tg blocking autophagic flux [33] - that DR5 is not
subject to autophagic degradation in Tg-treated cells.
Together, these results indicate that autophagy and
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autophagosomal membranes are not required for Tg-
induced cell death.
In conclusion, our data indicate that Tg-induced cell
death involves a non-autophagic function of LC3B up-
stream of procaspase-8 cleavage. To our knowledge, this
is the first time that LC3 has been implicated as a con-
tributor to cell death induced by a classical ER stressor.
Tg-induced cell death depends on independent pro-death
stimuli from components of the PERK UPR arm, with ATF4
and CHOP, but not PERK, converging on the regulation of
DR5 and LC3B protein levels
Tg-induced apoptosis requires the UPR [8–11, 13]. To
enhance our understanding of ER stress-induced cell
death initiation, we in the following parts sought to
Fig. 2 Tg-induced cell death partially requires LC3B. a LNCaP cells were transfected for 2 d with the indicated siRNAs (siCtrl = non-targeting
control siRNA). Subsequently, cells were treated with 100 nM Tg or 0.01% DMSO vehicle control (“DMSO”, also transfected with siCtrl) in the
additional presence of 2.5 μg/ml propidium iodide to stain dead cells. Cell death was monitored and quantified with the IncuCyte ZOOM as
described in Materials and Methods, and displayed as relative values normalized to those obtained in the siCtrl+Tg condition after 48 h of
treatment (mean value set to 1). Mean ± SEM from 6 independent experiments. b LNCaP cells were transfected and treated as in (a). After 30 h of
treatment with Tg or DMSO (also transfected with siCtrl), whole cell lysates were prepared and subjected to western blotting with the indicated
antibodies; cl-PARP = cleaved PARP. The positions of molecular weight markers are indicated to the left. One representative blot out of 4
independent experiments. c Quantification of cleaved PARP protein levels, normalized to the tubulin loading control and then to the siCtrl+Tg
condition (mean value set to 1). Mean ± SEM from 4 independent experiments. d HCT116 cells were transfected and treated as in (a), followed by
quantification of cell death by propidium iodide staining after 39 h of treatment. Mean ± SEM from 5 independent experiments. e HCT116 cells
were transfected as in (d). After 30 h of treatment with Tg or DMSO (also transfected with siCtrl), whole cell lysates were prepared and subjected
to western blotting with the indicated antibodies; p55/53 casp8 = procaspase-8, p43/41 casp8 = cleaved caspase-8, cl-PARP = cleaved PARP. The
asterisk indicates a nonspecific band. One representative blot out of 3 independent experiments. f Quantification of cleaved caspase-8 bands
(upper panel) and cleaved PARP levels (lower panel), normalized to the tubulin loading control and then to the siCtrl+Tg condition (mean value
set to 1). Mean ± SEM from 3 independent experiments. For (a, c, d, and f): Dots represent individual values, with a separate color for each
experiment. *P < 0.05, ***P < 0.001, ns; not significant, One-way ANOVA compared to the Tg + siCtrl condition
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elucidate how the various components of the UPR inte-
grate on the regulation of cell death and the expression
of DR5 and LC3B. Knockdown of PERK, ATF4, or
CHOP strongly diminished Tg-induced cell death in
LNCaP cells (Fig. 3), with comparable reductions in cell
death observed with each siRNA and with each target
(~ 70–85% reduction). The inhibition of Tg-induced cell
death was accompanied by a very strong decrease (~
80% reduction or more) in Tg-induced cleavage of
caspase-3 and PARP (Fig. 4a-c). The dependency on
PERK for Tg-induced cell death was likely at least partly
due to PERK kinase activity, since treatment with the
PERK inhibitor GSK2606414 significantly reduced Tg-
induced cell death, albeit to a lesser degree than that ob-
served upon PERK knockdown (Fig. 3). Similar results
were obtained in HCT116 cells; knockdown of PERK,
ATF4, or CHOP significantly reduced Tg-induced cell
death (Additional file 2: Figure S9), as well as the cleav-
age of caspase-3 and PARP (Additional file 3: Figure
S10A-C). Overall, the effects of the knockdowns were
more pronounced in LNCaP than in HCT116 cells (Fig.
3; Fig. 4a-c; Additional file 2: Figure S9; Additional file 3:
Figure S10A-C) in spite of similar knockdown efficien-
cies (Fig. 4a, d and e; Additional file 3: Figure S10A,
S10D, S10E), indicating that the degree of dependency
on the PERK arm for Tg-induced cell death can differ
between cell types. The PERK inhibitor significantly re-
duced Tg-induced cell death also in HCT116 cells (Add-
itional file 2: Figure S9). Taken together, these results
demonstrate that Tg-induced cell death substantially de-
pends on PERK, ATF4 and CHOP in both LNCaP and
HCT116 cells.
Under UPR-inducing conditions, the PERK-ATF4-
CHOP axis is often assumed to operate in a linear fash-
ion, i.e. effects of ATF4 are ascribed to PERK acting via
ATF4, and effects of CHOP are ascribed to PERK acting
via ATF4 to CHOP. Tg-induced upregulation of ATF4
protein levels did indeed depend on PERK in both
LNCaP and HCT116 cells, since it was strongly reduced
upon knockdown of PERK at both early (6 h) and late
(30 h) time points (6 h: Additional file 4: Figure S11A,
S11D; 30 h: Fig. 4a and d; Additional file 3: Figure S10A,
S10D). Surprisingly, however, ATF4 silencing had little
or no effect on CHOP protein levels at neither of the
Fig. 3 Tg-induced cell death requires PERK, ATF4 and CHOP. LNCaP cells were transfected for 2 d with the indicated siRNAs (siCtrl = non-
targeting control siRNA), employing two different siRNA oligoes for each target (designated by − 1 and − 2). Subsequently, cells were treated with
0.02% DMSO (“DMSO”, also transfected with siCtrl) or 100 nM Tg in the absence of presence of 100 nM PERK inhibitor GSK2606414 (PERKi, also
transfected with siCtrl), and the additional presence of 2.5 μg/ml propidium iodide in all conditions to stain dead cells. Cell death was monitored
and quantified with the IncuCyte ZOOM as described in Materials and Methods, and displayed as relative values normalized to those obtained in
the siCtrl+Tg condition after 48 h of treatment (mean value set to 1). Mean ± SEM from 4 independent experiments. Dots represent individual
values, with a separate color for each experiment. ***P < 0.001, One-way ANOVA compared to the Tg + siCtrl condition
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time points in neither of the cell lines (6 h: Additional
file 4: Figure S11A, S11D; 30 h: Fig. 4a and e; Additional
file 3: Figure S10A, S10E). Thus, the inhibition of Tg-
induced cell death observed upon ATF4 knockdown is
very unlikely to be mediated via downregulation of
CHOP. Conversely, CHOP silencing, which also dimin-
ished Tg-induced cell death, did not significantly alter
Tg-induced upregulation of ATF4 protein levels (6 h:
Additional file 4: Figure S11A, S11D; 30 h: Fig. 4a and d;
Additional file 3: Figure S10A, S10D). We conclude that
during Tg-induced cell death in LNCaP and HCT116
cells, ATF4 and CHOP are both required, yet provide
their pro-death stimuli independently of each other.
Interestingly, the pro-death roles of ATF4 and CHOP
converged in that each of them were individually re-
quired for Tg-induced upregulation of DR5 mRNA and
protein levels, as well as LC3B mRNA and protein levels,
in both LNCaP and HCT116 cells (Fig. 4a, f, and g; Add-
itional file 3: Figure S10A, S10F, S10G; Additional file 4:
Figure S11; Additional file 5: Figure S12). In contrast,
PERK silencing, which was also required for Tg-induced
cell death, failed to significantly alter Tg-mediated up-
regulation of DR5 and LC3B protein levels (Fig. 4a, f,
and g; Additional file 3: Figure S10A, S10F, S10G; Add-
itional file 4: Figure S11A, S11D). Consequently, PERK
must be required for an essential Tg-induced pro-death
signal that is independent of the regulation of DR5 and
LC3B expression, and likely also independent of its regu-
lation of ATF4 and CHOP. Remarkably, PERK silencing
did reduce Tg-induced upregulation of DR5 and LC3B
at the mRNA level in both cell lines (Additional file 4:
Figure S11; Additional file 5: Figure S12). This may be
explained by the fact that PERK silencing efficiently di-
minished Tg-mediated induction of ATF4 in both cell
lines, whereas it only partially or transiently reduced Tg-
induced upregulation of CHOP in LNCaP and HCT116
cells, respectively (Fig. 4a, d and e; Additional file 3: Fig-
ure S10A, S10D, S10E; Additional file 4: Figure S11A,
S11D). ATF4 protein upregulation would thus seem to
be required for Tg-mediated induction of DR5 and
LC3B mRNA expression. The observation that PERK si-
lencing did not block Tg-induced upregulation of DR5
and LC3B protein levels, even though it diminished Tg-
mediated induction of ATF4 and Tg-mediated upregula-
tion DR5 and LC3B at the mRNA level, indicates that
Tg signals an essential, PERK-independent stimulation
of DR5 and LC3B expression at the protein level (pro-
tein synthesis and/or stabilization), which does not re-
quire ATF4 upregulation. Importantly, unlike PERK
silencing, ATF4 knockdown efficiently brought down
basal ATF4 protein levels in addition to the levels in-
duced by Tg (Fig. 4a and d; Additional file 3: Figure
S10A, S10D). This suggests that basal ATF4 levels are
required for Tg-mediated enhancement of DR5 and
LC3B at the protein level. Additionally, a threshold level
of CHOP seems to be required, since CHOP silencing
also blocked Tg-induced upregulation of DR5 and LC3B
protein.
Tg-induced cell death partially requires IRE1 and XBP1 in
LNCaP, but not HCT116 cells
We next turned to examine the roles played by the IRE1
and ATF6 UPR arms in Tg-induced cell death. In
LNCaP cells, knockdown of IRE1 or XBP1 partially re-
versed Tg-induced cell death, ranging between ~ 20–
40% reductions of cell death depending on the siRNA
used (Fig. 5a; see Additional file 5: Figure S13A and
Fig. 6a, d and e for knockdown efficiencies). This was ac-
companied by a ~ 30–50% reduction of Tg-induced
caspase-3 and PARP cleavage upon IRE1 or XBP1 deple-
tion (Fig. 6a-c). ATF6 silencing did not significantly alter
Tg-induced cell death (Fig. 5a; see Additional file 5: Fig-
ure S13B for knockdown efficiency). A pro-death role
for IRE1 has previously been suggested via signaling to
JNK [39, 52–54], and JNK is required for Tg-induced
cell death in LNCaP cells [7]. In agreement, the JNK in-
hibitor JNK-IN-8 efficiently diminished Tg-induced cell
death (Fig. 5a). In HCT116 cells, Tg-induced cell death
remained the same, or slightly higher, upon knockdown
of IRE1, XBP1 or ATF6, or upon JNK-IN-8 co-treatment
(Fig. 5b; see Additional file 5: Figure S13C, S13D, and
Additional file 5: Figure S14A, S14D, S14E for knock-
down efficiencies). The increases in Tg-induced cell
death observed with the first siRNAs against IRE1 and
ATF6 were not reproducible with a second set of siR-
NAs (Fig. 5b). Furthermore, there were no significant
(See figure on previous page.)
Fig. 4 Tg-induced caspase activation requires PERK, ATF4 and CHOP, whereas Tg-mediated upregulation DR5 and LC3B protein levels depends
on individual contributions from ATF4 and CHOP, but not PERK. a LNCaP cells were transfected for 2 d with the indicated siRNAs (siCtrl = non-
targeting control siRNA), employing two different siRNA oligoes for each target (designated by − 1 and − 2). After 30 h of treatment with 100 nM
Tg or 0.02% DMSO vehicle control (also transfected with siCtrl), whole cell lysates were prepared and subjected to western blotting with the
indicated antibodies; Casp3 = caspase-3 (only cleaved caspase-3 bands are shown), cl-PARP = cleaved PARP. The positions of molecular weight
markers are indicated to the left. The shift towards the slower migrating PERK band in Tg-treated cells reflects induction of PERK phosphorylation
by Tg. One representative blot out of at least 3 independent experiments. b-g Quantifications of western blots from a, normalized to the tubulin
loading control and then to the siCtrl+Tg condition. Mean ± SEM from 4 (b-d, f, and g) or 3 (e) independent experiments. Dots represent
individual values, with a separate colour for each experiment. *P < 0.05, **P < 0.01, ***P < 0.001, ns; not significant, One-way ANOVA compared to
the Tg + siCtrl condition
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changes in Tg-induced caspase-3- or PARP cleavage
with any of the siRNAs, nor with JNK-IN-8 (Additional
file 5: Figure S14 A-C). Together, this indicates that the
IRE1 and ATF6 arms do not play any significant role in
Tg-induced cell death in HCT116 cells, whereas the
IRE1-, but not ATF6 arm is partially required in LNCaP
cells.
The IRE1-XBP1 axis is partially required for Tg-mediated
upregulation of DR5-, but not LC3B protein levels
In LNCaP cells, IRE1 or XBP1 silencing resulted in a sub-
stantial reduction (~ 60–70% on average) of Tg-induced
upregulation of DR5 at the protein level (Fig. 6a and f). In
contrast, knockdown of IRE1 or XBP1 did not significantly
alter the upregulation of LC3B (Fig. 6a and g). ATF6 silen-
cing or treatment with the JNK inhibitor neither reduced
Tg-mediated upregulation of DR5 nor LC3B (Fig. 6a, f,
and g). In HCT116 cells, there were no significant alter-
ations of Tg-induced upregulation of either DR5 or LC3B
upon knockdown of IRE1, XBP1 or ATF6, nor upon treat-
ment with the JNK inhibitor. Of note, however, there were
tendencies of a ~ 40–50% reduction in Tg-induced upreg-
ulation of DR5 protein with both XBP1-targeting siRNAs
(Additional file 5: Figure S14A, S14F). The reduction in
Tg-mediated upregulation of DR5 protein levels upon si-
lencing of the IRE1-XBP1 axis in LNCaP cells may at least
in part explain the partial requirement for IRE1 and XBP1
in Tg-induced cell death in this cell line.
IRE1 does not play an opposing role in Tg-mediated
upregulation of DR5 mRNA levels
IRE1 has been reported to induce DR5 mRNA decay via
its RIDD activity, and thereby play an opposing role in
Tg-induced apoptosis [9]. This activity was reported to
occur at relatively early time points after Tg treatment;
in the presence of Actinomycin D to block the transcrip-
tion of new DR5 mRNA, IRE1 silencing was shown to
increase DR5 mRNA levels after 4–8 h of treatment with
Tg in HCT116 cells [9]. If IRE1-mediated DR5 mRNA
decay should play a role in DR5-mediated induction of
apoptosis in Tg-treated cells, then IRE1 silencing must
result in higher DR5 mRNA levels also in the absence of
Actinomycin D. However, this was not examined in the
above-mentioned study. To obtain more knowledge on
the role of IRE1 in Tg-induced cell death, we tested
whether IRE1 knockdown would increase DR5 mRNA
levels after 6 h of Tg treatment in LNCaP and HCT116
cells. In spite of efficient silencing, IRE1 knockdown did
not lead to any increase in DR5 mRNA levels, in any of
the cell lines (Fig. 7). Tg-induced DR5 mRNA levels
remained unaltered also upon XBP1 silencing (Fig. 7; the
reduction in DR5 mRNA observed with one of the
XBP1-targeting siRNAs was neither reproduced by the
second XBP1-targeting siRNA nor in a second experi-
ment). Thus, compensatory activation of IRE1 in re-
sponse to XBP1 depletion [9, 71] did not appear to
result in reduced levels of DR5 mRNA. In conclusion,
IRE1-mediated DR5 mRNA decay does not seem to have
any measurable net effect on DR5 mRNA levels in
LNCaP and HCT116 cells.
The IRE1-XBP1 axis is required for the second phase
activation of JNK by Tg
Tg activates JNK in a biphasic manner in LNCaP cells,
with an early activation phase that is discernible after 30
min, yet gone within 6 h, followed by a second activation
phase that is discernible from around 12 h and which is
sustained at least until 48 h after Tg treatment [7]. At
the 30 h time point shown in Fig. 6a, we noted that IRE1
or XBP1 silencing efficiently reversed Tg-mediated up-
regulation of phospho-JNK levels in LNCaP cells, with
the strongest effect observed upon XBP1 knockdown.
Similar results were obtained in HCT116 cells (Add-
itional file 5: Figure S14A). This indicates that the IRE1-
XBP1 axis is required for the second activation phase of
JNK. To determine whether IRE1 and XBP1 would be
required also for the first activation phase, we performed
a time-course experiment, where we treated IRE1- or
XBP1-depleted LNCaP cells with Tg for 30 min, 6 h, or
30 h. Tg increased phospho-JNK levels in the expected
biphasic manner (Fig. 8), and in agreement with the
above-mentioned results, IRE1 or XBP1 silencing con-
sistently and efficiently reduced Tg-induced upregula-
tion of phospho-JNK at the 30 h time point, again with
XBP1 depletion being more effectual than IRE1 deple-
tion. In contrast, IRE1- or XBP1-depletion did not show
any consistent reduction of Tg-induced upregulation of
phospho-JNK levels at the 30 min time point (Fig. 8), in
(See figure on previous page.)
Fig. 5 Tg-induced cell death involves IRE1, XBP1, and JNK in LNCaP, but not HCT116 cells (a and b) LNCaP (a) or HCT116 (b) cells were
transfected for 2 d with the indicated siRNAs (siCtrl = non-targeting control siRNA), employing two different siRNA oligoes for each target
(designated by − 1 and − 2). Subsequently, cells were treated with 0.02% DMSO (“DMSO”, also transfected with siCtrl) or 100 nM Tg in the
absence of presence of 0.5 μM JNK inhibitor JNK-IN-8 (JNKi, also transfected with siCtrl), and the additional presence of 2.5 μg/ml propidium
iodide in all conditions to stain dead cells. Cell death was monitored and quantified with the IncuCyte ZOOM as described in Materials and
Methods, and displayed as relative values normalized to those obtained in the siCtrl+Tg condition after 48 h (a) or 39 h (b) of treatment (mean
value set to 1). Mean ± SEM from 4 independent experiments. Dots represent individual values, with a separate color for each experiment.
*P < 0.05, **P < 0.01, ***P < 0.001, ns; not significant, One-way ANOVA compared to the Tg + siCtrl condition
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spite of efficient knockdown and a potent ability of IRE1
depletion to abolish Tg-mediated XBP1s mRNA eleva-
tion at 30 min (Fig. 8; Additional file 5: Figure S15).
IRE1 and XBP1s thus seem to be required for the second
JNK activation phase, but not the first. Of note, the re-
duction in phospho-JNK levels observed upon IRE1- or
XBP1 knockdown was not caused by a reduction in total
JNK protein levels (Fig. 8). IRE1 has been reported
previously to activate JNK via TRAF2 [39, 40], i.e. via an
XBP1-independent IRE1 pathway. If this had been the
case in our experiments, we would have expected only
IRE1 knockdown and not XBP1 knockdown to abolish
Tg-induced JNK activation. Instead, we observed even
stronger effects upon XBP1 silencing compared to upon
IRE1 silencing. XBP1 knockdown brought down XBP1s
mRNA and protein levels more efficiently than IRE1
(See figure on previous page.)
Fig. 6 IRE1 and XBP1 are partially required for Tg-induced caspase activation and upregulation of DR5-, but not LC3B expression in LNCaP cells. a
LNCaP cells were transfected for 2 d with the indicated siRNAs (siCtrl = non-targeting control siRNA), employing two different siRNA oligoes for
each target (designated by − 1 and − 2). After 30 h of treatment with 0.02% DMSO (“DMSO”, also transfected with siCtrl) or 100 nM Tg in the
absence of presence of 0.5 μM JNK inhibitor JNK-IN-8 (JNKi, also transfected with siCtrl), whole cell lysates were prepared and subjected to
western blotting with the indicated antibodies; Casp3 = caspase-3 (only cleaved caspase-3 bands are shown), cl-PARP = cleaved PARP, p-JNK =
phospho-JNK. The positions of molecular weight markers are indicated to the left. In the presence of JNK-IN-8, the two p-JNK bands shift towards
slightly slower migration due to covalent binding of the inhibitor to the JNK1 and JNK2 isoforms. One representative blot out of at least 3
independent experiments. b-g Quantifications of western blots from (a), normalized to the tubulin loading control and then to the siCtrl+Tg
condition. Mean ± SEM from 4 (b-f) or 3 (g) independent experiments. Dots represent individual values, with a separate color for each experiment.
*P < 0.05, **P < 0.01, ***P < 0.001, ns; not significant, One-way ANOVA compared to the Tg + siCtrl condition
Fig. 7 IRE1 does not oppose Tg-induced upregulation of DR5 mRNA. a-d LNCaP (a and b) or HCT116 (c and d) cells were transfected for 2 d
with the indicated siRNAs (siCtrl = non-targeting control siRNA), employing two different siRNA oligoes for each target (designated by − 1 and −
2). Subsequently, cells were treated with 100 nM Tg or 0.01% DMSO (also transfected with siCtrl) for 6 h, and subjected to real-time RT-PCR to
quantify DR5 mRNA levels (a and c) or western blotting to validate efficient knockdown of IRE1 and XBP1s protein levels (b and d). In (a and c),
relative mRNA levels are shown normalized to the DMSO control-treated condition (set to 1 and indicated by the dotted line in the graphs), i.e.
the conditions shown are all with Tg treatment. Mean ± SD of triplicate measurements from one representative experiment out of two. Of note,
the reduction observed with siXBP1–1 in (a) was not reproducible. In (b and d), one representative blot out of 2 independent experiments
is shown
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knockdown (Fig. 6a and e; Fig. 8; Additional file 5: Fig-
ure S15C). Thus, the degree of abolishment of Tg-
induced upregulation of phospho-JNK levels correlated
with the degree of downregulation of XBP1s expression
levels. Our results thus suggest that IRE1 acts via XBP1s
to regulate the second phase activation of JNK during
Tg treatment. Since it is the second, sustained phase of
JNK activation that is required for Tg-induced apoptosis
[7, 72], the involvement of IRE1-XBP1 in this phase can
at least partly explain the requirement for the IRE1-
XBP1 axis in Tg-induced cell death of LNCaP cells.
Cell death induced by therapeutically relevant Tg analogs
display the same requirements for DR5, UPR components,
and JNK as cell death induced by Tg
To optimize the use of Tg prodrugs in cancer therapy,
we need to know if the Tg analogs that are produced
upon prodrug cleavage in vivo display the same mecha-
nisms of action as the mother compound Tg. The pro-
drugs that have been tested and shown promising results
in pre-clinical and clinical trials contain peptide se-
quences that upon cleavage produce the Tg analogs
Leu-8ADT [14, 57, 58] or βAsp-8ADT [15, 59, 73] (for
structures see Additional file 1: Figure S1A). These ana-
logs display a slower binding to SERCA than Tg, but just
like Tg they efficiently deplete ER Ca2+, activate a sus-
tained UPR, and induce apoptotic cell death in cancer
cells [10]. However, it is not further known whether Tg
analogs and Tg induce cell death via the same molecular
mechanisms or not. Now that we had elucidated many
of the key molecular requirements for Tg-induced cell
death, and noting the slower kinetics of the therapy-
relevant analogs for SERCA inhibition, we were curious
to compare their effects to those of Tg in more detail.
To that end, we put Leu-8ADT and βAsp-8ADT
through the same focused RNAi screen as we had done
with Tg, and assessed the effects on cell death in both
LNCaP and HCT116 cells. Strikingly, Leu-8ADT and
βAsp-8ADT both showed virtually identical molecular
requirements for cell death induction as those we had
observed with Tg, in both cell lines. Thus, Leu-8ADT-
and βAsp-8ADT-induced cell death showed a strong re-
quirement for caspase-8 and DR5, but not DR4, in both
LNCaP and HCT116 cells (Additional file 5: Figure S16).
Furthermore, just like with Tg, cell death partially re-
quired FADD in LNCaP cells, whereas the effect of
FADD knockdown was weak in HCT116 cells. Also, with
Leu-8ADT and βAsp-8ADT there was an overall trend
of a further increase in cell death upon TRADD knock-
down, and while Fas knockdown produced a slight in-
crease in cell death in HCT116 cells, Fas was partially
required for Leu-8ADT- and βAsp-8ADT-induced cell
death in LNCaP cells (Additional file 5: Figure S16).
PERK, ATF4, and CHOP were all required for Leu-
Fig. 8 The IRE1-XBP1 axis is required for the second phase of JNK activation by Tg in LNCaP cells. LNCaP cells were transfected for 2 d with the
indicated siRNAs (siCtrl = non-targeting control siRNA), employing two different siRNA oligoes for each target (designated by − 1 and − 2).
Subsequently, cells were treated with 100 nM Tg or 0.01% DMSO vehicle control (also transfected with siCtrl) for 30 min, 6 h, or 30 h, and
subjected to western blotting with the indicated antibodies; p-JNK = phospho-JNK, cl-PARP = cleaved PARP
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8ADT- and βAsp-8ADT-induced cell death in both cell
lines, with the strongest requirement observed in LNCaP
(Additional file 5: Figure S17), i.e. exactly like we had
observed with Tg. Lastly, while ATF6 depletion did not
alter cell death in any of the cell lines, IRE1, XBP1, and
JNK were partially required for Leu-8ADT- and βAsp-
8ADT-induced cell death in LNCaP, but not HCT116
cells (Additional file 5: Figure S18), again as we had ob-
served with Tg. In conclusion, these results indicate that
therapeutically relevant Tg analogs induce the same key
molecular pro-death stimuli as Tg. Mechanistic investi-
gations of the cytotoxic actions of Tg can thus be ex-
pected to have important value not only for our
understanding of UPR-induced cell death but also for
our understanding and potential to optimize the thera-
peutic use of Tg prodrugs.
Discussion
Understanding the molecular mechanisms of Tg-induced
cell death is important for enhancing our knowledge of
ER stress-induced apoptosis, opening up for the develop-
ment of novel treatment and combination treatment strat-
egies towards diseases that are associated with lowered ER
Ca2+ levels, chronic ER stress and cell death [2–4], as well
as in Tg-based targeted cancer therapy [16]. Although
much is known about downstream cell death-inducing
mechanisms in response to unmitigated ER stress, e.g. the
involvement of caspases and various Bcl-2 protein family
members [5, 74, 75], the initiating events - and how the
various components of the UPR integrate on them - are
less well defined. Moreover, the role played by autophagy
and ATG proteins, which are very often implicated in cell
fate decisions [28], is uncertain.
Numerous studies have shown that ER stress-induced cell
death-initiation involves death receptor-associated activa-
tion of caspase-8 [9, 13, 17–22, 26, 27]. However, it is un-
clear whether one member of the death receptor family is
more important than others, or whether ER stress-induced
cell death may generally co-require several different death
receptors. DR5 has been shown to play a prominent role in
ER stress-induced cell death [9, 13, 18, 21], but other stud-
ies have indicated the involvement of DR4 [19], TNFR1
[26], or Fas [27]. Direct comparison has been made only
with regard to the related DR4 and DR5. DR4 and DR5
knockout cell lines were shown to display comparable defi-
ciencies in Tg-induced cell death, suggesting that DR4 and
DR5 contribute equally to ER stress-induced cell death
[20]. Recent studies have however demonstrated that cau-
tion must be exerted with regard to drawing strong conclu-
sions from death receptor knockout studies [21, 76]. Thus,
whereas Tg-induced apoptosis was only minimally or par-
tially abolished in DR5 HCT116 knockout cells [21, 76] and
could not be further reduced by either DR5- or caspase-8-
targeting siRNAs [21], Tg-induced cell death was nearly
completely abolished by siRNA-mediated depletion of DR5
or caspase-8 in the parental cell line [21]. This indicates
that the long-term DR5 ablation in the knockout cell line
had caused adaptation to a rewired ER stress- responsive
apoptotic pathway [21]. More acute depletion methods
may thus be more appropriate than permanent knockouts
to elucidate the endogenous roles of the various death re-
ceptors in ER stress-induced cell death. Using an RNAi-
based approach, we showed that Tg-induced cell death
depended strongly on DR5 and caspase-8 in both LNCaP
and HCT116 cells, whereas DR4 was not required in either
cell line, indicating a dominant role of DR5 versus DR4 in
ER stress-induced cell death. In line with this, Tg was previ-
ously shown to upregulate DR5 but not DR4 mRNA ex-
pression in 10 different cell lines [17], and another study
showed that Tg potently upregulated DR5, but elicited little
or no increase in DR4, TNFR1, or Fas mRNA expression in
two different cell lines [9]. It should be noted that those
studies examined neither the protein expression levels nor
the potential requirement for DR4, TNFR1, or Fas in ER
stress-induced apoptosis. A recent study found that glucose
deprivation (which induces many forms of cellular stress,
including ER stress) could increase DR4 protein levels with-
out increasing DR4 mRNA levels in HeLa cells, and glucose
deprivation-induced cell death showed comparable depend-
encies on DR4 and DR5 [77]. Interestingly, our results
showed that Fas was partially required for Tg-induced cell
death in LNCaP, but not HCT116 cells, suggesting a co-
requirement for DR5 and Fas in ER stress-induced cell
death in LNCaP cells (yet with the strongest dependency
on DR5). TRADD was not required for Tg-induced cell
death in any of the cell lines, suggesting that TNFR1 and
members of the DR3 and DR6 family are not involved. In
fact, TRADD silencing tended to increase rather than de-
crease Tg-mediated cell death and caspase activation. This
finding may be related to previous observations showing
that TRADD can protect cells from TRAIL-induced apop-
tosis [78, 79], in part via competition with FADD for bind-
ing to the DR4/DR5 receptor complex [78]. However, given
that ligand-independent death receptor complexes may dif-
fer in their requirement for adaptor proteins (see further
discussion below), our data cannot formally exclude a po-
tential TRADD-independent pro-death involvement of
DR1, DR3 or DR6 members in Tg-induced cell death. In
any case, the severe reduction in Tg-induced cell death that
we observed upon knockdown of DR5 in both LNCaP and
HCT116 indicates a major requirement for DR5. In conclu-
sion, although other death receptors may also play a con-
tributing role, our results and those of others [9, 13, 17, 18,
20, 21] strongly suggest that DR5 is a main hub for ER
stress-mediated initiation of cell death across a range of dif-
ferent cell types.
Our observation that TRAIL-targeting RNAi did not
alter Tg-induced cell death is in line with previous studies
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showing that Tg and other ER stressors can trigger DR5-
dependent apoptosis independently of the DR5 ligand
(TRAIL) [9, 18]. Interestingly, Tg-induced DR5 multimeri-
zation and caspase-8 activation most likely occur at intra-
cellular sites [9]. It is not known whether caspase-8
activation by this ER stress-induced, ligand-independent
intracellular DR5 involves the same DISC components as
classical ligand-activated plasma membrane DISCs. Fas
can undergo ligand-independent multimerization, leading
to FADD recruitment and caspase-8 activation in response
to UV light or anticancer drugs, but under those condi-
tions the death receptor aggregation occurs at the plasma
membrane, and not intracellularly [80, 81]. Tg was shown
to induce DR5-FADD-caspase-8 complexation in
HCT116 cells [9], but it was not examined if, or to which
degree, this occurred at the intracellular sites of DR5 mul-
timerization. The requirement for FADD in Tg-induced
cell death and caspase activation has not been examined
previously. Surprisingly, we observed that, unlike DR5
knockdown, FADD knockdown did not significantly re-
duce Tg-induced caspase-8 cleavage or cell death in
HCT116 cells. Moreover, in LNCaP cells, FADD depletion
had a markedly weaker effect on Tg-induced cell death
and caspase activation than that observed upon DR5- or
caspase-8 depletion. This may suggest that even very low
amounts of FADD are sufficient to mediate caspase-8 re-
cruitment to DR5 under ER stress conditions. However,
RNAi-mediated reduction of FADD protein levels is re-
portedly sufficient to abolish TRAIL- and Fas-mediated
caspase activation and cell death [82, 83]. Taken together,
our data, therefore, more likely indicate that ER stress-
induced DR5-dependent intracellular activation of
caspase-8 and cell death involves adaptor proteins other
than FADD, in particular in HCT116 cells. In line with
this, a previous study showed that apoptosis induced by
overexpression of DR5 (i.e. without ligand present) in
HeLa cells was not inhibited by the expression of a domin-
ant negative form of FADD [84].
The current study is, to the best of our knowledge, the
first to identify a role for LC3B in ER stress-induced cell
death. Specifically, LC3B was partially required for
caspase-8 activation and cell death in Tg-treated cells.
LC3B is best known for its role in autophagy. When at-
tached to the phagophore (the autophagosomal mem-
brane that matures into the autophagosome), LC3B acts
to recruit autophagic cargo via binding to adaptor pro-
teins called autophagy receptors, e.g. SQSTM1 (p62)
[85]. The phagophore contains a number of ATGs, in-
cluding FIP200 and ATG5, which are required for LC3
recruitment and phagophore maturation [67–69]. The
LC3-related GABARAP protein family is also essential
for autophagosome formation, but not for LC3 recruit-
ment [70]. Previous studies have indicated that autopha-
gosomal membranes can serve as platforms for
intracellular caspase-8 activation in response to treat-
ment with proteasome or sphingosine kinase inhibitors
[63–65]. Specifically, recruitment of caspase-8 to au-
tophagic membranes was suggested to occur via ATG5-
FADD-caspase-8 [63, 65] and/or LC3-p62-caspase-8 [64,
65] complexes. In our experiments, knockdown of
FIP200, ATG5, or the GABARAPs all failed to reduce
Tg-induced cell death. This indicates that autophagoso-
mal membranes are unlikely to serve as platforms for
Tg-induced caspase-8 activation and that a non-
autophagic function of LC3B is involved instead. Of
note, LC3B can interact with p62 also when not present
on autophagosomal membranes [86, 87]. Thus, a puta-
tive Tg-induced LC3B-p62-caspase-8 interaction could
potentially explain our observations. However, p62 de-
pletion did not reduce Tg-induced cell death (data not
shown), thus implicating the involvement of other, yet to
be defined mechanisms of LC3B-dependent caspase-8
activation during ER stress.
Tg and other ER stressors are known to induce cell
death via the UPR, but the contributions and integration
of the individual UPR components to cell death and its
initiation remain incompletely defined. In order to address
these important questions, we have in the current study
systematically examined how each of the central UPR
components (PERK, ATF4, CHOP, IRE1, XBP1, and
ATF6) regulates Tg-induced caspase activation and cell
death in LNCaP and HCT116 cells. Moreover, to gain
more insight into UPR-mediated regulation of cell death
initiation, and having identified DR5 and LC3B as import-
ant initiating factors of Tg-induced cell death in both cell
lines, we simultaneously delineated how the various UPR
components regulate DR5- and LC3B expression. Previous
studies on the role of the UPR arms in ER stress-induced
cell death and DR5 expression have examined either only
one cell line (leaving uncertainty regarding potential cell
type-specific effects) or only a subset of UPR components
(leaving uncertainty about the wider picture), using only
one siRNA per target (leaving uncertainty to potentially
confounding off-target effects). To overcome these limita-
tions, we set out to target each of the main UPR compo-
nents with two different siRNAs per target in two
different cell lines and assess the effects on Tg-induced
cell death, caspase activity, and DR5- and LC3B expres-
sion. We found that the PERK arm components PERK,
ATF4, and CHOP were all required for Tg-induced cell
death in both LNCaP and HCT116 cells, yet acted in par-
allel rather than as a linear pathway. CHOP has been
found to be required for ER stress-induced DR5 upregula-
tion and cell death in several studies [9, 13, 18], and this
has been assumed to be the result of CHOP acting down-
stream of the PERK-ATF4 axis [9, 18, 88, 89]. Importantly,
however, this assumption has not been experimentally
tested. Remarkably, we observed that ATF4 depletion
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failed to abolish Tg-mediated upregulation of CHOP, and
we could, therefore, conclude that ATF4 and CHOP pro-
vide their pro-death stimuli independently of each other.
Interestingly, the roles of ATF4 and CHOP converged in
that each of them was essential for Tg-mediated upregula-
tion of DR5- and LC3B expression at both the mRNA and
protein levels. PERK depletion abolished Tg-mediated up-
regulation of ATF4 protein expression and reduced Tg-
mediated upregulation of DR5- and LC3B mRNA levels,
but surprisingly, and in contrast to the effect of ATF4 or
CHOP silencing, it failed to significantly reduce Tg-
mediated upregulation of DR5 and LC3B at the protein
level. Unlike PERK silencing, which merely abrogated Tg-
mediated ATF4 upregulation, ATF4 silencing in Tg-
treated cells depleted ATF4 protein levels to well below
the basal levels found in DMSO control-treated cells. This
indicates that PERK-dependent upregulation of ATF4 is
required for Tg to increase DR5- and LC3B mRNA ex-
pression, whereas Tg-mediated increase in DR5- and
LC3B protein expression requires basal ATF4 levels, but
not PERK. Tg-mediated upregulation of DR5 and LC3B
mRNA and protein levels also requires an independent
contribution from CHOP. Together, our findings point to
a cell death-essential, Tg-induced regulation of DR5 and
LC3B at the protein level (enhanced protein synthesis
and/or increased protein stabilization), which is dependent
on ATF4 and CHOP, but not on PERK. The specific regu-
lation of DR5 and LC3B at the protein level may be
equally or even more important than their regulation at
the mRNA level. An exclusive regulation of DR5 at the
protein level has been observed in response to glucose
deprivation of HeLa cells, where DR5 protein levels rose
in the 24–72 h time period in the absence of any increase
in DR5 mRNA levels [77]. Under those conditions, the up-
regulation of DR5 protein levels was abolished upon silen-
cing of ATF4, but not CHOP [77], whereas the putative
role of PERK or other kinases of the integrated stress re-
sponse was not examined. The role of CHOP in DR5
regulation may thus differ depending on the stress condi-
tion. Regulation of LC3B at the protein level has not been
much studied, but interestingly, it has been shown that T
cell activation increases LC3B protein expression exclu-
sively at the translational level [90]. In summary, our de-
lineation of the roles played by the components of the
PERK UPR arm indicates that Tg-induced ER stress trig-
gers cell death via ATF4- and CHOP-dependent upregula-
tion of DR5 and LC3B protein expression, as well as via
other mechanisms, which require PERK (Fig. 9).
Interestingly, we observed a cell type-dependent role
of IRE1 in ER stress-induced cell death; whereas IRE1
was partially required for Tg-mediated cytotoxicity in
LNCaP cells, its depletion did not significantly alter Tg-
induced cell death in HCT116 cells. Mechanistically, we
could link the pro-death role of IRE1 to a previously
unrecognized XBP1-dependent activation of JNK. JNK
initiates a complex and varied set of intracellular signals
that affect cell death and survival in a context- and cell
type-dependent manner [91]. Intriguingly, although Tg
increased phospho-JNK levels in an IRE1/XBP1-
dependent manner in both cell lines, JNK was selectively
required for Tg-induced cell death in LNCaP, and not in
Fig. 9 Schematic depiction of main conclusions. Thapsigargin (Tg)
binds to and blocks SERCA (the ER Ca2+ pump), thus causing ER
Ca2+ depletion and ER stress. ER stress upregulates LC3B and DR5
protein levels in a manner that requires individual contributions
from ATF4 and CHOP. Tg-induced activation of caspase-8 (casp8),
caspase-3 (casp3), and apoptosis is strongly dependent on DR5, and
partially dependent on LC3B. PERK is required for Tg-induced
caspase activation and apoptosis, but not for upregulation of LC3B-
and DR5 protein levels. Thus, PERK delivers an essential pro-death
signal via a different pathway. The IRE1-XBP1 axis is partially required
for Tg-induced upregulation of DR5, but not LC3B. Moreover, IRE1-
XBP1 is required for the second-phase activation of JNK by Tg,
which contributes to caspase activation and apoptosis in a cell type-
dependent manner with JNK being required for Tg-induced cell
death in LNCaP but not HCT116 cells
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HCT116 cells. Together, these results provide an explan-
ation to the observed cell type-dependent role of IRE1 in
that the IRE1-XBP1-JNK pathway contributes to ER
stress-induced cell death only in cell types that are sensi-
tive to the pro-death effects of JNK (Fig. 9). This may at
least in part explain why IRE1 is found to be required
for ER stress-induced cell death in some cell types [49,
53, 54] while having no effect on cell death in others
[18, 92–94]. We could not observe any pro-survival ef-
fect of IRE1 or XBP1 during Tg-induced cell death in
the cell lines we examined. Moreover, and in contrast to
what has been suggested in HCT116 cells previously [9],
we could not observe any opposing role of IRE1 on Tg-
mediated upregulation of DR5 mRNA in HCT116 or
LNCaP cells. Thus, IRE1-activated RIDD of DR5 mRNA
does not appear to be a general pro-survival mechanism
for IRE1, and IRE1 does not appear to play a general op-
posing role during ER stress-induced cell death.
The IRE1-XBP1 axis has been widely described to provide
adaptive and anti-apoptotic signals during ER stress [47–49,
74, 95–98]. A current model proposes that XBP1-mediated
pro-survival signals pre-dominate over other IRE1-mediated
effects during mild, resolvable ER stress, whereas IRE1
RIDD- and IRE1-TRAF2-JNK pro-death signals override the
XBP1-mediated pro-survival signals during cytotoxic, unre-
solvable ER stress [49, 74, 96, 97]. Importantly, however, the
exact role played by the IRE1-XBP1 axis during cytotoxic
ER stress has not been directly experimentally tested previ-
ously. Our results in LNCaP cells provide the first direct
demonstration of a pro-death role for XBP1 during cyto-
toxic ER stress conditions. In line with this finding, two pre-
vious studies have shown that high levels of XBP1s can
mediate pro-apoptotic signals. Firstly, it was shown that
overexpression of XBP1s induced apoptosis in human um-
bilical endothelial cells [99]. Secondly, a recent report
showed that while XBP1 mediated adaptive signals at non-
cytotoxic, low levels of ER stress, it could mediate pro-
apoptotic effects via upregulating the expression of the tran-
scription factor KLF9 at cytotoxic, high levels of ER stress in
WI38 human fibroblasts [100]. Although the effect of XBP1
depletion on ER stress-induced cell death was not examined
in the latter report, these studies and ours together suggest
that the IRE1-XBP1 axis provides pro-death signals under
high-level ER stress conditions and that this may contribute
to ER stress-induced cell death in several different cell types.
By demonstrating that Tg-induced JNK-activation depends
on the IRE1-XBP1 axis, we have identified a novel path for
ER stress-induced pro-death signals. Previously, IRE1 was
shown to activate JNK via direct interaction between IRE1
and TRAF2 [39, 40]. Overexpression studies with IRE1β in
HEK293T cells indicated that the IRE1-TRAF2 interaction
requires the IRE1 kinase-, but not RNAse activity [40], i.e.
that it is independent of the IRE1-XBP1 axis. Consequently,
although we cannot exclude that XBP1 may be required for
the IRE1-TRAF2-JNK axis in a cell type-dependent manner
(i.e. in LNCaP and HCT116, but not HEK293T cells), we
consider it most likely that our results reflect a novel mech-
anism of JNK activation during unresolvable ER stress.
Interestingly, Tg enhances JNK activity in two distinct tem-
poral phases consisting of a rapid and transient phase that
provides pro-survival signals [72], followed by a second, sus-
tained phase that mediates pro-death signals [7]. The mo-
lecular mechanisms responsible for JNK activation in the
first versus the second phase may be different. Whereas the
IRE1-TRAF2-JNK pathway, which is activated very rapidly
(within 10–30min) after Tg stimulation [39, 40, 72], drives
the first phase of JNK activation, the mechanism responsible
for the second phase, sustained activation of JNK is un-
known. Our results indicate that, at least in LNCaP and
HCT116 cells, the second phase activation of JNK is medi-
ated by an IRE1-XBP1-dependent mechanism. It is import-
ant to note that although the IRE1-TRAF2-ASK1-JNK
pathway is well documented [39, 52, 101], direct and con-
clusive evidence for its role in mediating ER stress-induced
cell death is lacking. For example, Tg failed to induce apop-
tosis in ASK1 knockout MEFs [39], but the role of IRE1,
TRAF2, and JNK were not examined. More detailed evi-
dence has been demonstrated in studies of the effects of
RNF13 or Bak + Bim/PUMA overexpression [52, 101], but it
is unclear how those conditions compare with general ER
stress-inducing conditions. Thus, the roles of the IRE1-
TRAF2-ASK1-JNK- and the herein defined IRE1-XBP1-JNK
pathways in ER stress-induced cell death should be carefully
examined in future studies. In addition to IRE1-XBP1-
dependent regulation of JNK, we found that IRE1 and XBP1
were partially required for Tg-induced upregulation of DR5
protein in LNCaP cells. This was not mediated by JNK since
the JNK inhibitor did not affect DR5 protein levels. More-
over, interference with IRE1, XBP1, or JNK did not affect
the levels of LC3B in Tg-treated cells. In summary, the re-
quirement for IRE1 and XBP1 in Tg-induced cell death in
LNCaP cells may in part be explained by IRE1-XBP1-
dependent regulation of JNK and in part by IRE1-XBP1-
dependent regulation of DR5 protein levels (Fig. 9).
Lastly, we found that the two therapeutically relevant
Tg analogs Leu-8ADT and βAsp-8ADT induced cell
death with virtually identical molecular requirements as
those observed for Tg in both LNCaP and HCT116 cells.
These are important findings that could not be taken for
granted, since the analogs differ from Tg by the addition
of a 12-aminododecanoyl side-chain (in position O-8), to
which an amino acid residue (either a leucine or an as-
partate residue) resulting from proteolysis-mediated pro-
drug peptide cleavage, is attached. Compared to Tg, the
analogs show differences in their interaction with
SERCA (burial of the extended prodrug linker) and dis-
play a slower binding to SERCA, even though the ana-
logs bind to the same binding site [10, 15, 102, 103].
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The differences result in higher concentrations being
needed for cell death induction [10]. Interestingly, how-
ever, Leu-8ADT is, for reasons that still need to be fully
elucidated [10], a more potent killer than βAsp-8ADT.
Across 3 different cancer cell lines, 50% of maximal cell
death induction was reached at 1.4- to 4.6-fold higher
concentrations of Leu-8ADT than Tg, whereas 5- to 13-
fold higher concentrations than Tg were required for
βAsp-8ADT [10]. In spite of these differences, our
current results indicate that when cancer cells are ex-
posed to cytotoxic concentrations of Leu-8ADT or
βAsp-8ADT they are killed via the same mechanisms as
when they are exposed to Tg. This is encouraging and
vital information for future use and optimization of Tg
prodrugs in cancer treatment, including in combination
therapy. With regard to the latter, the βAsp-8ADT-
producing Tg prodrug has been successfully combined
with the antiangiogenic drug tasquinimod to completely
eradicate tumor growth in breast cancer xenografts
[104]. Compared to conventional chemotherapy, Tg has
the advantage of efficiently killing tumor cells independ-
ently of their proliferation rate [105]. Additionally, Tg
blocks autophagy [33], thereby avoiding the putative
pro-survival effects from autophagic activity that are
often observed in response to therapy, and which may
contribute to therapeutic resistance [106]. Of note, the
Tg analogs paralleled the effect of Tg in efficiently inhi-
biting autophagic activity (data not shown). Thus, Tg
prodrugs may find use in combination with therapeutic
treatments that otherwise induce protective autophagy.
The Tg-mediated block in autophagic flux likely in-
creases the ability of Tg and the analogs to induce cell
death since the consequential inhibition of autolysoso-
mal LC3B degradation increases the protein levels of this
contributing factor to ER stress-induced apoptosis.
Conclusion
In conclusion, our systematic study has provided important
new insights into both general and cell type-specific signal-
ing mechanisms of cell death-induction upon Tg-induced
ER stress, thus contributing to increase our understanding
of ER stress-induced cell death and providing knowledge
that is of relevance to diseases associated with UPR-
induced cell death, as well as to Tg-based cancer therapy.
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